Abstract P1-07-06: Adjunctive statistical standardization of quantitated adjuvant HER2 and very low statistically standardized HER2 in CCTG MA.27
Judith-Anne Chapman, Karen J. Taylor(Edinburgh Cancer Research), Haji Chalchal, Catherine Elliott, Matthew J. Ellis(University of California, Davis), Shakeel Virk, Vered Stearns(Johns Hopkins University), Jane Bayani(Ontario Institute for Cancer Research), Tammy Piper, Edith A. Perez(Unknown), George W. Sledge(Caris Life Sciences (United States)), Manuela Rabaglio(University Hospital of Bern), Karen A. Gelmon(University of British Columbia), David D’Souza(London Cancer), James N. Ingle(Mayo Clinic), John M.S. Bartlett(Edinburgh Cancer Research), Silvana Spadafora(Sault Area Hospital), Sandip Sengupta, Paul E. Goss(Princess Margaret Hospital), L. E. Shepherd, Richard Tozer, G. Thomas Budd, Timothy J. Whelan, Mary Anne Quintayo(Ontario Institute for Cancer Research), Rafat Ansari, Bingshu E. Chen(University of Iowa)
Cited by 0
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k